Morgan Stanley Upgrades Roche Holding (ROG:SW) (RHHBY) to Equalweight Apr 24, 2026 02:49AM
Morgan Stanley Upgrades Roche (RHHBY) to Equalweight Apr 24, 2026 02:47AM
Roche (RHHBY) PT Lowered to $46 at Morgan Stanley Apr 7, 2026 10:28AM
Argus Upgrades Roche (RHHBY) to Buy Apr 6, 2026 08:48AM
Cantor Fitzgerald: 'We now expect apitegromab to have near complete market share' Mar 19, 2026 02:11PM


Jan 16, 2026 12:55AM Goldman Sachs Upgrades Roche Holding (ROG:SW) (RHHBY) to Neutral
Dec 19, 2025 02:32PM Genentech reaches drug pricing agreement with U.S. government
Dec 19, 2025 02:24PM 14 of 17 Leading Drug Manufactures Now Part of Trump Most Favored Nation Efforts
Dec 10, 2025 08:20AM Genentech's giredestrant cuts breast cancer recurrence risk by 30%
Nov 11, 2025 03:27AM Deutsche Bank Upgrades Roche Holding (ROG:SW) (RHHBY) to Hold
Oct 27, 2025 02:55AM Jefferies Downgrades Roche Holding (ROG:SW) (RHHBY) to Underperform
Oct 17, 2025 04:23PM Genentech reports positive Phase III results for uveitic macular edema drug
Oct 16, 2025 11:49AM Genentech launches direct-to-patient program for flu drug Xofluza
Oct 2, 2025 05:00AM HSBC Upgrades Roche Holding (ROG:SW) (RHHBY) to Buy
Sep 23, 2025 02:20PM Baird on Lineage Cell Therapeutics Inc. (LCTX): 'Incrementally positive following partner's R&D Day'
Aug 25, 2025 02:31PM Genentech breaks ground on $700 million manufacturing facility in North Carolina
Aug 8, 2025 04:02AM Morgan Stanley Downgrades Roche Holding (ROG:SW) (RHHBY) to Underweight
Aug 8, 2025 04:00AM Morgan Stanley Downgrades Roche (RHHBY) to Underweight
Jul 18, 2025 11:45AM FDA rejects Genentech's Columvi combination for lymphoma treatment
Jun 20, 2025 11:48AM Roche's (RHHBY) Genentech presents results from Phase 3 study of Lunsumio
May 12, 2025 10:49AM Roche (RHHBY) to invest $550 million for manufacturing hub expansion
Apr 28, 2025 03:25AM HSBC Downgrades Roche Holding (ROG:SW) (RHHBY) to Hold
Apr 16, 2025 10:16AM BNP Paribas Exane Starts Roche Holding (ROG:SW) (RHHBY) at Outperform
Feb 13, 2025 12:13AM UBS Upgrades Roche Holding (ROG:SW) (RHHBY) to Buy
Feb 11, 2025 06:00AM Bernstein explains why this Big Pharma stock should 'continue to work'
Feb 4, 2025 11:46AM FDA Approves Genentech’s Susvimo as Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Feb 4, 2025 03:32AM Roche Holding (ROG:SW) (RHHBY) PT Raised to CHF265 at Deutsche Bank
Jan 2, 2025 12:39PM TD Cowen on Trump Tariffs and Other Risks: 'Where Does Pharma Stand?'
Dec 9, 2024 09:54AM CFRA Starts Roche (RHHBY) at Hold
Nov 5, 2024 07:35AM Erste Group Downgrades Roche Holding (ROG:SW) (RHHBY) to Hold
Sep 13, 2024 05:32AM BofA Securities Upgrades Roche Holding (ROG:SW) (RHHBY) to Buy
Sep 13, 2024 04:02AM Deutsche Bank Downgrades Roche Holding (ROG:SW) (RHHBY) to Sell
Sep 11, 2024 01:22PM Roche stock down 5% after disappointing drug trial data update
Aug 6, 2024 02:23AM Roche Holding (ROG:SW) (RHHBY) PT Raised to CHF290 at Berenberg
Jul 29, 2024 09:53AM Roche to accelerate weight loss drugs development after positive trials - report
Jul 17, 2024 11:45AM Genentech’s Vabysmo Showed Extended Durability, Continued Efficacy and a Consistent Safety Profile in Long-Term Diabetic Macular Edema (DME) Study
Jul 12, 2024 02:32AM Morgan Stanley Reiterates Underweight Rating on Roche Holding (ROG:SW) (RHHBY)
Jun 17, 2024 08:37AM Jefferies Reiterates Hold Rating on Roche Holding (ROG:SW) (RHHBY)
Jun 17, 2024 06:29AM Deutsche Bank Reiterates Buy Rating on Roche Holding (ROG:SW) (RHHBY)
Jun 14, 2024 05:25AM Roche Holding (ROG:SW) (RHHBY) PT Raised to CHF305 at Bernstein SocGen Group